GT
49
2
MAT
45
2
BAC
41
3
CA
32
3
MMM
40
3
FOX
70
-3
PHM
50
2
CVS
32
3
KO
44
-2
GOOGL
64
-2
NI
70
2
O
26
-4
CFG
44
4
MAC
58
4
USB
53
3
PLD
45
5
K
56
3
EW
57
2
EOG
30
-2
PG
46
3
GT
49
2
MAT
45
2
BAC
41
3
CA
32
3
MMM
40
3
FOX
70
-3
PHM
50
2
CVS
32
3
KO
44
-2
GOOGL
64
-2
NI
70
2
O
26
-4
CFG
44
4
MAC
58
4
USB
53
3
PLD
45
5
K
56
3
EW
57
2
EOG
30
-2
PG
46
3
Financhill
Back

SpringWorks Therapeutics 10K Form

Sell
39

SWTX
SpringWorks Therapeutics

Last Price:
$37.10
Seasonality Move:
4.38%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SWTX News And Ratings

See the #1 stock for the next 7 days that we like better than SWTX

SWTX Financial Statistics

Sales & Book Value

Annual Sales: $5.4M
Cash Flow: $-27.2M
Price / Cash Flow: 0
Annual Sales: $7.16
Price / Book: 5.14

Profitability

EPS (TTM): -3.89000
Net Income (TTM): $-275.2M
Gross Margin: $5M
Return on Equity: -51.38%
Return on Assets: -44.72%

SpringWorks Therapeutics Earnings Forecast

Key SpringWorks Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 3 years for SWTX is 92.25%.
  • The Selling, General & Administrative Expenses for SWTX have been equal to 3,626.79% of Gross Profit Margin.
  • The Research & Development expenses have been 2,762.75% of Revenue.
  • The Net Earning history of SWTX is -5,968.50% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

SpringWorks Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: SWTX
CUSIP: 85205L
Website: springworkstx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 6.16
Quick Ratio: 5.8

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SWTX Technical Analysis vs Fundamental Analysis

Sell
39
SpringWorks Therapeutics (SWTX) is a Sell

Is SpringWorks Therapeutics a Buy or a Sell?